Recombinant Human Myosin-7 (MYH7), partial

中文名稱：

人MYH7重組蛋白
品名簡稱：

Recombinant Human MYH7 protein, partial
貨號：

CSB-BP015300HU
說明書：

MSDS Datasheet
規(guī)格：

￥3168
圖片：
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

純度：

Greater than 85% as determined by SDS-PAGE.
基因名：

MYH7
Uniprot No.：

P12883
種屬：

Homo sapiens (Human)
蛋白長度：

Partial
來源：

Baculovirus
分子量：

18.1 kDa
表達(dá)區(qū)域：

1-109aa
氨基酸序列

MGDSEMAVFGAAAPYLRKSEKERLEAQTRPFDLKKDVFVPDDKQEFVKAKIVSREGGKVTAETEYGKTVTVKEDQVMQQNPPKFDKIEDMAMLTFLHEPAVLYNLKDRY
Note: The complete sequence may include tag sequence, target protein sequence, linker sequence and extra sequence that is translated with the protein sequence for the purpose(s) of secretion, stability, solubility, etc.
If the exact amino acid sequence of this recombinant protein is critical to your application, please explicitly request the full and complete sequence of this protein before ordering.
蛋白標(biāo)簽：

C-terminal 6xHis-tagged
產(chǎn)品提供形式：

Liquid or Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
緩沖液：

If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.
復(fù)溶：

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
儲存條件：

Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
保質(zhì)期：

The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
貨期：

Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
注意事項：

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet & COA：

Please contact us to get it.

產(chǎn)品評價

靶點詳情

功能：

Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle.
基因功能參考文獻(xiàn)：
1. Of the 52 hypertrophic cardiomyopathy patients 12 (23.1%) had MYH7 variants. PMID: 29386531
2. A family that demonstrates the diverse HCM phenotypes associated with a single MYH7 mutation. PMID: 29343710
3. Mutation in MYH7 was identified as Restrictive Cardiomyopathy - causing mutation. PMID: 27339502
4. MYH7-V878A and CACNA1C-A1594V mutations were detected in a Chinese Family with Hypertrophic Cardiomyopathy. Among those with only the MYH7-V878A mutation, subject III-7 showed abnormal ECG recordings, asymmetric septal hypertrophy, and myocardial fibrosis, and subjects II-13 and III-15 showed some abnormal repolarization, borderline LV wall thickness, and normal cardiac magnetic resonance (CMR) findings. PMID: 28866666
5. Asn391Thr mutation of MYH7 is a malignant mutation for hypertrophic cardiomyopathy and that mutation carriers should get effective treatment to prevent sudden death. PMID: 29743414
6. Double MYH7 CTTNA3 heterozygotes showed a variable clinical expression of arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy. One carrier of double mutations in CTTNA3 and MYH7 genes did not fulfill the current diagnostic criteria for cardiomyopathy. PMID: 28699631
7. Data provide evidence that MYH7 mutations contributed to 24.4% MYBPC3 mutations of hypertrophic cardiomyopathy (HCM) cases, that MYBPC3 constitute the preeminent cause of HCM and that both mutations are phenotypically indistinguishable. PMID: 29121657
8. Digenic inheritance of two novel variants in TNNT2 and MYH7 is associated with a severe form of dilated cardiomyopathy. PMID: 28642161
9. MYH7-V878A is a hot spot among ethnic Han Chinese with a high penetrance. PMID: 28777849
10. Unlike previous Hypertrophic cardiomyopathy (HCM)mutations studied at the molecular level using human beta-cardiac myosin, early-onset HCM mutations lead to significantly larger changes in the fundamental biomechanical parameters and show clear hyper-contractility PMID: 27974200
11. Gly716Arg allele carriers have an extremely poor prognosis, and the females seem to have a longer life expectancy than males. To the best of our knowledge, this study is the largest cohort study of the Gly716Arg allele. PMID: 27161882
12. We investigated a male with familial familial hypertrophic cardiomyopathy with restrictive physiology and we identified a novel missense mutation p.Arg719Leu of beta-myosin heavy chain (MYH7) gene PMID: 27910300
13. ur results suggest that the basis for the pathogenic effect of the R1845W and H1901L mutations of the MYH7 are primarily structural rather than functional. Further analyses are needed to identify the primary trigger for the histological changes seen in muscle biopsies of patients with L1793P and E1883K mutations. PMID: 28125727
14. Two novel heterozygous proline substitutions located in exon 31 of MYH7 within its rod domain:c.4309G>C (p.Ala1437Pro) and c.4301G>C (p.Arg1434Pro) is causing skeletal myopathies. PMID: 27519903
15. MYH7 gene mutation is associated with Early-Onset Hypertrophic Cardiomyopathy. PMID: 27483260
16. family members who carried both the MYH7-A719H and MYOZ2-L169G mutations had more severe symptoms of hypertrophic cardiomyopathy, including sudden cardiac death, than those with only the MYH7 mutation PMID: 28296734
17. Chinese family with dual LQT1 and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1, MYH7, MYLK2, and TMEM70 mutations. PMID: 25825456
18. A novel heterozygous mutation (MYH7, p.Asn885Thr), and a variant of uncertain significance (TNNT2, p.Arg296His) were identified in 2 patients with familial hypertrophic cardiomyopathy. PMID: 27082122
19. Multidimensional structure-function relationships in human beta-cardiac myosin from population-scale genetic variation. PMID: 27247418
20. BNP, but not mutations in MYH7 may have a role in sudden cardiac death in children with hypertrophic cardiomyopathy PMID: 26773184
21. novel mutation in the MYH7 gene in a family with distal myopathy and core-like features PMID: 27005958
22. We reported a case of mirror-type dextrocardia who developed HCM in adulthood exhibiting multiple genetic mutation related to sarcomere proteins PMID: 25863306
23. analysis of the interaction between residues Glu-497 in the relay domain and Arg-712 in the converter domain of human beta-cardiac myosin PMID: 26446785
24. A beta-myosin molecule's ADP release rate depends exponentially on the applied load, in qualitative agreement with cardiac muscle, which contracts with a velocity inversely proportional to external load. PMID: 26239258
25. Results in this family show that mutation in MYH7 can lead to restrictive or mixed cardiomyopathy. PMID: 25422285
26. MYH7 mutation is associated with Inherited Cardiomyopathy. PMID: 25937619
27. no significant difference in the prevalence of the studied mutations between the patients with Hypertrophic cardiomyopathy and the healthy controls (p>0.05). PMID: 24566549
28. This study demonstrated that two families with MYH7 distal myopathy associated with cardiomyopathy and core formations. PMID: 25695922
29. The molecular characterization of the four myosin skip residues also provides a guide to modeling the effects of rod mutations causing cardiac and skeletal myopathies. PMID: 26150528
30. Mutations in the converter region of beta myosin heavy chain are associated with adverse prognosis of patients with cardiomyopathies, although there are differences between mutations. PMID: 25935763
31. MYH7-R1053Q was found to be a common mutation in Finnish patients with hypertrophic cardiomyopathy. PMID: 24888384
32. 3 family members with a dominant mutation in distal rod of MYH7 [c.5401G> A (p.Glu1801Lys)] with a complex phenotype of Laing Distal Myopathy like phenotype, left ventricular noncompaction cardiomyopathy and Fiber Type Disproportion at muscle biopsy PMID: 25576864
33. study shows faster cross-bridge kinetics and increase in energetic costs of tension generation of sarcomeres from hypertrophic cardiomyopathy (HCM) patients with the R403Q MYH7 mutation compared to mutation-negative patients; increased tension cost might contribute to HCM disease in patients carrying the R403Q mutation PMID: 24928957
34. A novel genetic variant in the coding regions of MYH7 gene was identified in a Chinese Left ventricular noncompaction-family. The results support the previous evidence that MYH7 is a pathogenic gene for Left ventricular noncompaction. PMID: 25550050
35. the association between Ebstein anomaly, Left ventricular noncompaction and mutations in MYH7 (Review) PMID: 23794396
36. MYH7 defects are a major cause of genetic cardiomyopathies, including LVNC in adults and children. PMID: 25547560
37. Report sex-related differences in myosin heavy chain beta expression in atria from failing and nonfailing hearts. PMID: 24878771
38. Case Report: familial Ebstein's anomaly, left ventricular noncompaction, and ventricular septal defect associated with an MYH7 mutation. PMID: 25444217
39. Data indicate nine novel mutations in the genes encoding myosin VI, myosin VIIA and myosin XVA in hearing-impaired individuals from Israeli Jewish and Palestinian Arab families. PMID: 24105371
40. This report widens the clinical and pathological phenotypes, and the genetics of MYH7 mutations leading to skeletal muscle diseases. PMID: 24664454
41. A novel p.G407C mutation in the beta-myosin heavy chain gene (MYH7) was identified to be responsible for familial hypertrophic cardiomyopathy in a family. PMID: 24963656
42. Left ventricular non-compaction was found to be associated with a novel MYH7 mutation. PMID: 24726209
43. We describe MYH7 as an additional causative gene for AD-CCD. PMID: 24828896
44. Transfecting human beta-MHC V606M into the mouse cardiac alpha-MHC gene caused hypertrophic cardiomyopathy without left ventricular hypertrophy, disarray of myofibers, and interstitial fibrosis. Cyclosporine or Arg453Cys or Arg719Trp worsened the phenotype. PMID: 24829265
45. MYH7 gene mutation segregates with disease in a family with autosomal dominant transmission of congenital heart defects including Ebstein anomaly PMID: 23956225
46. 8 known polymorphic MYH7 variants and 2 intronic variations but no missense or pathological mutations were found in 58 Venezuela hypertrophic cardiomyopathy cases. PMID: 24758099
47. The first detailed biochemical kinetic analysis of the motor domain of the human beta-cardiac myosin carrying the R453C mutation, is reported. PMID: 24344137
48. MYH7 mutations reduce force generating capacity of sarcomeres at maximal and submaximal [Ca(2)]. These hypocontractile sarcomeres may represent the primary abnormality in patients with MYH7 mutations. PMID: 23674513
49. Perfomed proteomic analysis on a transgenic mouse model of severe cardiac hypertrophy; compared data to dataset of heart failure found MYH7, IGFBP7, ANXA2, and DESM to be biomarker candidates for heart failure. PMID: 23713052
50. observations expand the clinical spectrum of laing distal myopathy with the MYH7 mutation PMID: 23707328
顯示更多

收起更多
相關(guān)疾病：

Cardiomyopathy, familial hypertrophic 1 (CMH1); Myopathy, myosin storage, autosomal dominant (MSMA); Scapuloperoneal myopathy MYH7-related (SPMM); Cardiomyopathy, dilated 1S (CMD1S); Myopathy, distal, 1 (MPD1); Myopathy, myosin storage, autosomal recessive (MSMB); Left ventricular non-compaction 5 (LVNC5)
亞細(xì)胞定位：

Cytoplasm, myofibril. Cytoplasm, myofibril, sarcomere.
蛋白家族：

TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
組織特異性：

Both wild type and variant Gln-403 are detected in skeletal muscle (at protein level).
數(shù)據(jù)庫鏈接：

HGNC: 7577

OMIM: 160500

KEGG: hsa:4625

STRING: 9606.ENSP00000347507

UniGene: Hs.719946